Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey

被引:10
|
作者
Kaur, Sukhpal [1 ]
Singh, Ajay [2 ]
Saini, Sushma [1 ]
Rohilla, Latika [1 ]
Kaur, Jasvir [1 ]
Chandi, Anadeep [3 ]
Kaur, Gurpreet [1 ]
Singh, Manjeet [9 ]
Kumar, Pramod [1 ]
Soni, Shiv Lal [10 ]
Kajal, Kamal [2 ]
Naik, Naveen B. [2 ]
Malhotra, Pankaj [4 ]
Verma, Sanjay [5 ]
Gupta, Madhu [6 ]
Devnani, Mahesh [7 ]
Das, Karobi [1 ]
Pandav, S. S. [8 ]
Puri, G. D. [2 ]
机构
[1] Govt Multispecial Hosp, Natl Inst Nursing Educ, Dept Nursing, Chandigarh, India
[2] Govt Multispecial Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India
[3] Govt Multispecial Hosp, Dept Obstet & Gynaecol, Chandigarh, India
[4] Govt Multispecial Hosp, Dept Internal Med, Chandigarh, India
[5] Govt Multispecial Hosp, Dept Paediat, Chandigarh, India
[6] Govt Multispecial Hosp, Dept Community Med, Chandigarh, India
[7] Govt Multispecial Hosp, Hosp Adm, Chandigarh, India
[8] Multispecial Hosp, Postgrad Inst Med Educ & Res, Ophthalmol, Chandigarh, India
[9] Govt Multispecial Hosp, Dept Med, Chandigarh, India
[10] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India
关键词
Adverse events; ChAdOx1; nCoV-19; coronavirus disease 2019; healthcare professionals; side effects; vaccination;
D O I
10.4103/ijmr.ijmr_1221_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) among the healthcare professionals. Methods: This was a descriptive cross-sectional survey. After taking clearance from the institutional ethics committee 1500 healthcare professionals, who had their vaccination in the past two weeks were selected. They were provided with an online survey proforma regarding adverse events following immunization (AEFIs) of COVID-19 vaccine developed using google forms with an informed consent form affixed to it. Results: A total of 1036 individuals participated in the study. The mean and median (inter quartile range) age of the participants was 37.7 +/- 11.25 and 35 (29-46) yr, respectively. Of these, 52.1 per cent were female, 29.3 per cent were doctors, 33.4 per cent were nurses and 9.5 per cent were paramedical staff. Forty six per cent participants experienced one or more minor AEFIs such as pain, tenderness, redness, etc. at the injection site. Fatigue (31.75%), generalized feeling of unwell (28.57%), muscle pain (23.16%) and fever (21.71%) were the most commonly reported systemic AEFIs followed by headache (20.07%), dizziness (10.03%) and joint pains (15.25%). Most of them experienced these AEFIs within 24 h of the first dose of administration. About 42 per cent of the participants took oral antipyretics/analgesics for managing the AEFIs. Interpretation & conclusions: ChAdOx1 nCoV-19 Corona Virus Vaccine was found to be associated with mild local and systemic AEFIs that were more common after the first dose as compared to the second dose. There adverse events could be dealt with oral over-the-counter medications, with no requirement of hospitalization.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [31] Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2
    Lee, Sang Won
    Lee, Hyun
    Lee, Sun-Kyung
    Moon, Ji-Yong
    Moon, SeolHwa
    Chung, Sung Jun
    Yeo, Yoomi
    Park, Tai Sun
    Park, Dong Won
    Kim, Tae-Hyung
    Sohn, Jang Won
    Yoon, Ho Joo
    Kim, Sang-Heon
    FRONTIERS IN MEDICINE, 2021, 8
  • [32] Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield™) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021
    Murali, Sharan
    Sakthivel, Manikandanesan
    Pattabi, Kamaraj
    Venkatasamy, Vettrichelvan
    Thangaraj, Jeromie Wesley Vivian
    Shete, Anita
    Varghese, Alby John
    Arjun, Jaganathan
    Kumar, Chethrapilly Purushothaman Girish
    Yadav, Pragya D.
    Sahay, Rima
    Majumdar, Triparna
    Dudhmal, Manisha
    Sivalingam, Azhagendran
    Dhanapal, Sudha Rani
    Durai Samy, Augustine
    Radhakrishnan, Vijayaprabha
    Muni Krishnaiah, Murali Mohan
    Arunachalam, Suresh
    Gandhi, Punita Muni Krishna
    Govindasamy, Elavarasu
    Chinnappan, Prabhakaran
    Sekar, Dhana Priya Vadhani
    Marappan, Prakash
    Pounraj, Ezhil
    Ganeshkumar, Parasuraman
    Jagadeesan, Murugesan
    Narnaware, Manish
    Bedi, Gagandeep Singh
    Kaur, Prabhdeep
    Murhekar, Manoj
    VACCINES, 2022, 10 (06)
  • [33] Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers
    Lim, Sera
    Lee, Yuil
    Kim, Dong Wan
    Park, Won Sang
    Yoon, Jung Hwan
    Lee, Jung Young
    INFECTION AND CHEMOTHERAPY, 2022, 54 (01) : 140 - 152
  • [34] Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience
    Kim, Si Ho
    Wi, Yu Mi
    Yun, Su Yeon
    Ryu, Jeong Seon
    Shin, Jung Min
    Lee, Eun Hui
    Seo, Kyung Hwa
    Lee, Sung Hee
    Peck, Kyong Ran
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 8
  • [35] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Goebel, Carl H.
    Heinze, Axel
    Karstedt, Sarah
    Morscheck, Mascha
    Tashiro, Lilian
    Cirkel, Anna
    Hamid, Qutyaba
    Halwani, Rabih
    Temsah, Mohamad-Hani
    Ziemann, Malte
    Goerg, Siegfried
    Muente, Thomas
    Goebel, Hartmut
    PAIN AND THERAPY, 2021, 10 (02) : 1309 - 1330
  • [36] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Carl H. Göbel
    Axel Heinze
    Sarah Karstedt
    Mascha Morscheck
    Lilian Tashiro
    Anna Cirkel
    Qutyaba Hamid
    Rabih Halwani
    Mohamad-Hani Temsah
    Malte Ziemann
    Siegfried Görg
    Thomas Münte
    Hartmut Göbel
    Pain and Therapy, 2021, 10 : 1309 - 1330
  • [37] Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor-Leste: A Cross-Sectional Survey
    da Costa, Juanina
    Nosoongnoen, Wichit
    Rungapiromnan, Watcharee
    Tragulpiankit, Pramote
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [38] Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)
    Roman, Gustavo C.
    Gracia, Fernando
    Torres, Antonio
    Palacios, Alexis
    Gracia, Karla
    Harris, Diogenes
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Reactogenicity and persistence of IgG antibodies against SARS-CoV-2 among recipients of ChAdOx1 nCoV-19 vaccine: A single center experience from Sri Lanka
    Govindapala, Dumitha
    Dhanaratna, Dhanuka
    Senarath, Uththara
    Lamabadusuriya, Dilusha
    Senaratne, Thamarasi
    Wijenayake, Wasantha
    Wijewardena, Dasun
    Nakkawita, Dilini
    Kawyangana, Pawanie
    Kulasekara, Upeksha
    Dharshan De Silva, Aruna
    Fernando, Nayana
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2023, 17 (01): : 36 - 43
  • [40] Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study
    Asefa, Adisu
    Derjachew, Nitsuh
    Belete, Abebe Muche
    Talargia, Feredegn
    Melese, Daniel Molla
    Getachew, Bekalu
    FRONTIERS IN PUBLIC HEALTH, 2023, 11